top of page
News
Publish Date
June 2020
Ross McLeod joins the Royal Australasian College of Surgeons for Swiss Federal Office of Public Health Study of Treatment of Hypercholesterolemia and Hyperlipidaemia with Ezetimibe-Containing Medicines
Ross McLeod has joined the Royal Australasian College of Surgeons (RACS) to contribute to a Health Technology Assessment (HTA) commissioned by the Swiss Federal Office of Public Health.
This study evaluates the efficacy, safety, cost-effectiveness, and budgetary impact of ezetimibe-containing medicines compared to statins or fenofibrate in treating hypercholesterolemia and mixed/combined hyperlipidemia.
McLeod brings extensive expertise in health economics and outcomes research, including modeling, and budget impact analysis
bottom of page